You searched for "specialty"
Keep calm and cut the carbon – improving sustainability in ophthalmology
As I dump my tenth pair of gloves into a non-recyclable clinical waste bin; dispose of another handful of plastic minims; or print another wad of single-sided discharge paperwork after a cataract surgery, the inconvenient truth of how these seemingly...Do steroids prevent progression to proliferative diabetic retinopathy (PDR)?
There is continuing debate on the merits of pan-retinal photocoagulation (PRP) for severe pre-proliferative and proliferative DR versus the newer therapies that inhibit vascular endothelial growth factor (VEGF). This has been hotly debated [1] following the publication of findings from...Setting up successful safe & efficient nurse-led intravitreal injection service
In September 2019, we organised a training course at Great Western NHS Hospital (GWH), Swindon, which provided presentations, discussions and hands-on wet lab experience on how to perform intravitreal injection using intravitreal assisted device (INVITRIA) for nurses and doctors from...Take part in the 'Whole Eye OCT Experience' at 100% Optical 2024
The Whole Eye OCT Experience is being delivered in association with The Partially Sighted Society: a charity that helps anybody living with vision loss make the best use of their remaining vision.ISS (International SPECTRALIS® Symposium) and Beyond
We are pleased to invite you to the 21st edition of the International SPECTRALIS® Symposium – and Beyond (ISS), which will be held for the first time in Heidelberg, Germany, on June 13-14, 2025, at the new Congress Center, just...
A scoping review of artificial intelligence tools for diabetic retinopathy in low- and middle-income countries
The authors conducted a scoping review to summarise the literature relating to artificial intelligence (AI) tools for diabetic retinopathy (DR) in low- and middle-income countries (LMICs). Eighty-one studies were included, following a comprehensive literature search. The majority of studies were...Intravitreal injections delivered by ophthalmic clinical nurse specialists
Intravitreal injections of the anti-vascular endothelial growth factor (anti-VEGF) agent ranibizumab, for the treatment of wet age-related macular degeneration (AMD) was approved by National Institute for Health & Care Excellence (NICE) in 2008 [1]. The Manchester Royal Eye Hospital (MREH),...
